Richard S. Finkel

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

10.4Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Longitudinal natural history of type I spinal muscular atrophy: a critical review

Orphanet Journal of Rare Diseases(2020)10.1186/s13023-020-01356-1

Top 7%

3.3DataRank

Top 7%76 citations

Simona Lucibello, Marco Perulli, Giorgia Coratti, Roberto De Sanctis, Maria Carmela Pera +7 more

Papers

Driven by 28 papers — median percentile 90. Top paper: “Longitudinal natural history of type I spinal muscular atrophy: a critical review”.

Longitudinal natural history of type I spinal muscular atrophy: a critical review

Orphanet Journal of Rare Diseases(2020)10.1186/s13023-020-01356-1

Top 7%

3.3DataRank

Top 7%76 citations

Simona Lucibello, Marco Perulli, Giorgia Coratti, Roberto De Sanctis, Maria Carmela Pera +7 more

Modeling disease trajectory in Duchenne muscular dystrophy

Neurology(2020)10.1212/wnl.0000000000009244

Top 7%

3.0DataRank

Top 7%73 citations

Yosef A. Berlow, William Triplett, Sean C. Forbes, Rebecca J. Willcocks, Dah-Jyuu Wang +17 more

Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study

Neurology(2020)10.1212/wnl.0000000000011051

Top 10%

2.2DataRank

Top 10%82 citations

Deborah Ridout, Mariacristina Scoto, Giorgia Coratti, Marion Main, R. Muni Lofra +25 more

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.44178

N/A

2.0DataRank · unranked

89 citations

Paula R. Clemens, Michela Guglieri, Edward C. Smith, Richard S. Finkel, M. Tulinius +92 more

Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy

Journal of Comparative Effectiveness Research(2020)10.2217/cer-2020-0095

Top 13%

1.6DataRank

Top 13%63 citations

Richard J. Barohn, Enrico Bertini, B. Chabrol, Giacomo P. Comi, Basil T. Darras +32 more

Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy

Neurology(2024)10.1212/wnl.0000000000208112

N/A

1.5DataRank · unranked

71 citations

Jesse M. Damsker, Michela Guglieri, Paula R. Clemens, Seth J. Perlman, Edward C. Smith +39 more

The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder

Human Mutation(2021)10.1002/humu.24308

N/A

0.921DataRank · unranked

20 citations

Amanda M. Levy, Jaya Punetha, Hua Gao, Nicholas Ah Mew, Kwame Anyane Yeboa +54 more

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study

PLoS Medicine(2020)10.1371/journal.pmed.1003222

N/A

0.729DataRank · unranked

82 citations

Laurie S. Conklin, Eric P. Hoffman, Paula R. Clemens, Jean K. Mah, Richard S. Finkel +22 more

Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons

Annals of Clinical and Translational Neurology(2025)10.1002/acn3.70165

N/A

0.363DataRank · unranked

10 citations

Michela Guglieri, Dragana Vučinić, Gyula Acsádi, John F. Brandsema, Claudio Bruno +22 more

The Spastic Paraplegia–Centers of Excellence Research Network (SP-CERN)

Neurology Genetics(2025)10.1212/nxg.0000000000200249

Top 61%

0.241DataRank

Top 61%4 citations

Vicente Quiroz, Kathryn Yang, Joshua Rong, Nicole Battaglia, Umar Zubair +19 more

Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years

Journal of the Peripheral Nervous System(2023)10.1111/jns.12557

N/A

0DataRank · unranked

5 citations

Richard S. Finkel, Carly E. Siskind, Shawna Feely, Joshua Burns, Mary M. Reilly +6 more

Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3

Neurology Clinical Practice(2024)10.1212/cpj.0000000000200298

N/A

0DataRank · unranked

14 citations

Deborah Ridout, Harriet Weststrate, Mariacristina Scoto, Annemarie Rohwer, Giorgia Coratti +32 more

Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3

Journal of Neuromuscular Diseases(2024)10.3233/jnd-230211

N/A

0DataRank · unranked

13 citations

Georgia Stimpson, Danielle Ramsey, Giorgia Coratti, Sally Dunaway Young, Anna Mayhew +29 more

TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations

Brain(2024)10.1093/brain/awae201

N/A

0DataRank · unranked

6 citations

Jack K. Donohue, Maya Hoke, Simone Thomas, Margo A. Peyton, Linh K. Vo +30 more

Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module

Neuromuscular Disorders(2024)10.1016/j.nmd.2024.08.006

N/A

0DataRank · unranked

4 citations

Matthew Civitello, Annemarie Rohwer, Emilio Albamonte, Jacqueline Montes, Allan M. Glanzman +28 more

Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients.

Scientific Reports(2025)10.1038/s41598-025-23758-6

N/A

0DataRank · unranked

3 citations

Rebecca Tobin, C. Degan, Ahmed Naveed, Michela Guglieri, Albert Jiménez-Requena +88 more

Charcot-Marie-Tooth disease type 1E: clinical natural history and molecular impact of PMP22 variants

Brain(2025)10.1093/brain/awaf219

N/A

0DataRank · unranked

3 citations

Christopher P. Ptak, Natalya Pashkova, Tiffany Grider, Tabitha A. Peterson, Davide Pareyson +47 more

Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study

Brain(2020)10.1093/brain/awaa323

N/A

0DataRank · unranked

92 citations

Shawna Feely, James M. Polke, Mariola Skorupinska, Laura Pérez, Rosemary Shy +55 more

Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children

Steroids(2025)10.1016/j.steroids.2025.109721

N/A

0DataRank · unranked

0 citations

Utkarsh J. Dang, Michael Ziemba, Yetrib Hathout, Paula R. Clemens, Jesse M. Damsker +17 more

A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores

Neurology(2020)10.1212/wnl.0000000000009035

N/A

0DataRank · unranked

53 citations

Stefan Sillau, Gyula Acsádi, Chelsea Bacon, Kimberly Dooley, Joshua Burns +32 more

GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome

Annals of Neurology(2020)10.1002/ana.25772

N/A

0DataRank · unranked

41 citations

Yaqun Zou, James E. Dunford, Jachinta Rooney, Goutam Chandra, Hui Xiong +29 more

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

Brain(2021)10.1093/brain/awab404

N/A

0DataRank · unranked

119 citations

Joanne Wuu, Caroline McHutchison, Ronald B. Postuma, Bradley F. Boeve, Ronald C. Petersen +34 more

Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy

Neuromuscular Disorders(2021)10.1016/j.nmd.2021.06.001

N/A

0DataRank · unranked

8 citations

Elaine McColl, Michael McDermott, William B. Martens, Michela Guglieri, Robert C. Griggs +42 more

Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG)

Journal of Neuromuscular Diseases(2023)10.3233/jnd-221560

N/A

0DataRank · unranked

64 citations

Basil T. Darras, Jerry R. Mendell, John W. Day, Nancy L. Kuntz, Anne M. Connolly +12 more

Combination disease‐modifying treatment in spinal muscular atrophy: A proposed classification

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51889

N/A

0DataRank · unranked

39 citations

Eugenio Mercuri, Richard S. Finkel, Janbernd Kirschner, Darryl C. De Vivo, Francesco Muntoni +9 more

Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints

Annals of Neurology(2023)10.1002/ana.26633

N/A

0DataRank · unranked

27 citations

David N. Herrmann, Davide Pareyson, Steven S. Scherer, Richard S. Finkel, Stephan Züchner +3 more

Development of an International SMA Bulbar Assessment for Inter-professional Administration

Journal of Neuromuscular Diseases(2023)10.3233/jnd-221672

N/A

0DataRank · unranked

13 citations

Katlyn McGrattan, Emily Johnson, Marise van der Heul, Tina Duong, Merete Bakke +12 more

Unusually severe muscular dystrophy upon in-frame deletion of the dystrophin rod domain and lack of compensation by membrane-localized utrophin

Med(2023)10.1016/j.medj.2023.02.005

N/A

0DataRank · unranked

8 citations

Joachim Schessl, Yaqun Zou, Michele Yang, Peter Heydemann, Robert Sufit +6 more

Richard S. Finkel

Indexed papers

Top data-sharing exemplar

Papers